{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:34:41Z","timestamp":1792251281260,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007359","name":"Fondazione Banco di Sardegna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRR-MAB-A2011-19237"],"award-info":[{"award-number":["PRR-MAB-A2011-19237"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson&apos;s Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009873","name":"Regione Autonoma della Sardegna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.nbd.2013.08.014","type":"journal-article","created":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T05:00:57Z","timestamp":1378011657000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model"],"prefix":"10.1016","volume":"60","author":[{"given":"Elisabetta","family":"Tronci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Stancampiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camino","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Collu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Devoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolo","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.08.014_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2010.03325.x","article-title":"Treatment of depressive symptoms in Parkinson's disease","volume":"18","author":"Barone","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2013.08.014_bb0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","article-title":"Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2013.08.014_bb0015","first-page":"271","article-title":"5-Hydroxytryptophan: a clinically-effective serotonin precursor","volume":"3","author":"Birdsall","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.nbd.2013.08.014_bb0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.08.014_bb9000","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2011.07.070","article-title":"Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia","volume":"198","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.08.014_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2006.03.118","article-title":"Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine","volume":"1094","author":"Carta","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2013.08.014_bb0025","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.08.014_bb0035","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00001756-199905140-00010","article-title":"Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex","volume":"14","author":"Casanovas","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2013.08.014_bb0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0028-3908(94)90177-5","article-title":"The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex","volume":"33","author":"Ceci","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.08.014_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-510X(99)00198-7","article-title":"The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease","volume":"172","author":"Choi","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2013.08.014_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1","article-title":"Depression in patients with Parkinson's disease","volume":"14","author":"Cummings","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.nbd.2013.08.014_bb0055","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.08.014_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-002-1381-y","article-title":"Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic","volume":"167","author":"Devoto","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2013.08.014_bb0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.neuropharm.2008.08.031","article-title":"Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat","volume":"55","author":"Dupre","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.08.014_bb0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.08.014_bb0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","article-title":"The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves L-DOPA efficacy","volume":"87","author":"Eskow","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.08.014_bb0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2013.08.014_bb0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.168.3933.849","article-title":"L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice","volume":"168","author":"Everett","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.08.014_bb0090","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjp.0702510","article-title":"Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat","volume":"126","author":"Haj\u00f3s","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.08.014_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajp.2012.05.011","article-title":"Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode","volume":"6","author":"Jangid","year":"2013","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.08.014_bb0100","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1523\/JNEUROSCI.21-08-02889.2001","article-title":"Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration","volume":"21","author":"Kirik","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.08.014_bb0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/123.7.1365","article-title":"Embryonic ventral mes-encephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"123","author":"Lee","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.08.014_bb0110","first-page":"1456","article-title":"L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.08.014_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2013.08.014_bb0120","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Mu\u00f1oz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.08.014_bb0125","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07598.x","article-title":"Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning","volume":"120","author":"Nahimi","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.08.014_bb0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.08.014_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study","volume":"25","author":"N\u00e8gre-Pag\u00e8s","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2013.08.014_bb0140","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.nbd.2013.08.014_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrneurol.2012.111","article-title":"Parkinson disease: serotonin reuptake inhibitors for depression in PD","volume":"8","author":"Perez-Lloret","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2013.08.014_bb0150","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.08.014_bb8587","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ana.22097","article-title":"Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia","volume":"68","author":"Rylander","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2013.08.014_bb0155","first-page":"7","article-title":"l-5-Hydroxytryptophan-(l-5-HTP) therapy","volume":"26","author":"Sano","year":"1972","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.nbd.2013.08.014_bb0160","series-title":"Innovative Models of CNS Disease; From Molecule to Therapy","first-page":"131","article-title":"Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimising behavioral assessment of outcome","author":"Schallert","year":"1999"},{"key":"10.1016\/j.nbd.2013.08.014_bb0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1440-1614.2002.01046.x","article-title":"Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis","volume":"36","author":"Shaw","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.08.014_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neures.2012.03.004","article-title":"Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study","volume":"73","author":"Tronci","year":"2012","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.08.014_bb0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pharmthera.2005.06.004","article-title":"Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan","volume":"109","author":"Turner","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2013.08.014_bb0180","first-page":"599","article-title":"Studies in the mechanism of action of serotonin precursors in depression","volume":"20","author":"Van Praag","year":"1984","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.nbd.2013.08.014_bb0185","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.0711839105","article-title":"Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:07:52Z","timestamp":1760850472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":39,"alternative-id":["S0969996113002350"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.08.014","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}